BridgeMD
New treatment option for Visual Field Defect
Official title Visual Plasticity Following Brain Lesions
ClinicalTrials.gov ID: NCT07105358
What this study is testing
- What it's testing
- The VIBRANT (Vision Improvement through Behavioral Rehabilitation And Neuroplasticity Training) study is a prospective, double-blind, crossover design (within-subject) in participants with homonymous hemianopia-a type of visual field loss resulting from damage to the post-chiasmatic visual pathways. It aims to investigate whether transcranial random noise stimulation (tRNS) combined with perceptual learning-based training has potential for improving visual impairments.
- This is a blinded study.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- A. Stroke, brain tumor, or traumatic brain injury patients
- At least 18 years of age.
- Capable of providing informed consent and complying with study procedures.
- Unilateral or bilateral focal brain damage causing loss of vision.
- At least three months post-stroke or traumatic brain injury, or a stable brain tumor within the past year.
You likely can't join if
- Severe CNS diseases or disorders unrelated to the focal lesion, which could interfere with study results.
- Severe mental health challenges that could interfere with study results, or current or recent (within the past 6 months) drug or alcohol abuse or...
- Vision loss resulting from ocular disease or disorder. B. Healthy volunteers (age-matched controls): Inclusion Criteria:
- At least 18 years of age.
- Capable of providing informed consent and complying with study procedures. Exclusion Criteria:
- Any CNS diseases or psychiatric disorders (e.g., epilepsy, schizophrenia) that would interfere with study results.
See the full eligibility criteria
- A. Stroke, brain tumor, or traumatic brain injury patients
- At least 18 years of age.
- Capable of providing informed consent and complying with study procedures.
- Unilateral or bilateral focal brain damage causing loss of vision.
- At least three months post-stroke or traumatic brain injury, or a stable brain tumor within the past year.
- Severe CNS diseases or disorders unrelated to the focal lesion, which could interfere with study results.
- Severe mental health challenges that could interfere with study results, or current or recent (within the past 6 months) drug or alcohol abuse or addiction as defined by DSM-5.
- Vision loss resulting from ocular disease or disorder. B. Healthy volunteers (age-matched controls): Inclusion Criteria:
- At least 18 years of age.
- Capable of providing informed consent and complying with study procedures. Exclusion Criteria:
- Any CNS diseases or psychiatric disorders (e.g., epilepsy, schizophrenia) that would interfere with study results.
- Previous head injury.
- Present or past (within past 6 months) drug or alcohol abuse or addiction based on DSM-5.
The study team makes the final eligibility decision.
Where it's taking place
- Washington D.C., District of Columbia, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Washington D.C., District of Columbia, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.